Mitchell Warren
Biographic Data
| ID | 3893142 |
|---|---|
| NAME | Mitchell Warren |
| GIVEN NAMES | Mitchell |
| FAMILY NAME | Warren |
| SIGNATURE | WARREN M |
| AFFILIATIONS | Weyerhaeuser (United States) |
| ORCID | 0000-0003-3626-7156 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 7 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1953 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Manifestations and Lived Experiences of Structural Racism for Racial and Ethnic Minority Communities Affected by HIV Across the United States
Objective: To elucidate some of the manifestations of structural racism as a root cause of racialized inequities in HIV in the context of COVID-19, centered through the lens of community members with lived experiences. Methods: We partnered with eight community-based organizations to conduct focus group discussions structured around COVID-19 and HIV-related experiences. We utilized inductive coding and thematic analysis. Results: We conducted 10 …
Promising results of HIV prevention trials highlight the benefits of collaboration in global health
This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV045445]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Forum for Collaborative Research, as an organization, also receives grants from the pharmaceutical industry but these are unrestricted and not s…
Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials
The successful demonstration that antiretroviral ( ARV ) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre‐exposure prophylaxis ( PrEP ) by those who are uninfected or as early treatment for prevention ( T4P ) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the …
Expanding Safer Sex Options
Although the female condom has been introduced into over 90 countries since 1997, it has only been accepted in sexual and reproductive health programmes as a mainstream method in a few. This paper describes introductory strategies developed by Ministries of Health and non-governmental organisations in Brazil, Ghana, Zimbabwe and South Africa, supported by UNAIDS, and the manufacturers of the female condom, which have significantly expanded the nu…
Epidemiology of the Psychosomatic Diseases
This expresses each cause of mortality for each year as a ratio of that for 1938 adopted as the base after adjustment for age differences in the population exposed
Expanding Safer Sex Options
Although the female condom has been introduced into over 90 countries since 1997, it has only been accepted in sexual and reproductive health programmes as a mainstream method in a few. This paper describes introductory strategies developed by Ministries of Health and non-governmental organisations in Brazil, Ghana, Zimbabwe and South Africa, supported by UNAIDS, and the manufacturers of the female condom, which have significantly expanded the nu…
Epidemiology of the Psychosomatic Diseases
This expresses each cause of mortality for each year as a ratio of that for 1938 adopted as the base after adjustment for age differences in the population exposed
Expanding Safer Sex Options
Although the female condom has been introduced into over 90 countries since 1997, it has only been accepted in sexual and reproductive health programmes as a mainstream method in a few. This paper describes introductory strategies developed by Ministries of Health and non-governmental organisations in Brazil, Ghana, Zimbabwe and South Africa, supported by UNAIDS, and the manufacturers of the female condom, which have significantly expanded the nu…
Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials
The successful demonstration that antiretroviral ( ARV ) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre‐exposure prophylaxis ( PrEP ) by those who are uninfected or as early treatment for prevention ( T4P ) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the …
Promising results of HIV prevention trials highlight the benefits of collaboration in global health
This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV045445]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Forum for Collaborative Research, as an organization, also receives grants from the pharmaceutical industry but these are unrestricted and not s…
Manifestations and Lived Experiences of Structural Racism for Racial and Ethnic Minority Communities Affected by HIV Across the United States
Objective: To elucidate some of the manifestations of structural racism as a root cause of racialized inequities in HIV in the context of COVID-19, centered through the lens of community members with lived experiences. Methods: We partnered with eight community-based organizations to conduct focus group discussions structured around COVID-19 and HIV-related experiences. We utilized inductive coding and thematic analysis. Results: We conducted 10 …
HIV/AIDS Research and Interventions (4 works) · Medicine (4 works) · Ethics in Clinical Research (2 works) · Family medicine (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Adolescent Sexual and Reproductive Health (1 works) · Applied Psychology (1 works) · Artificial Intelligence (1 works) · Business (1 works) · Champion (1 works)